Key result
The double alanine substitution TANA (T109A, N110A) in the Nav1.4 beta-1 subunit disrupted channel inactivation, suggesting the alpha/beta-1 interface is likely reversible.
Identification of a double mutant (T109A, N110A) in the Nav1.4 β1 subunit disrupts channel inactivation, providing insights into the structural interface of the sodium channel subunits.
This is the authors' abstract. We don't add key points for this paper.
The molecular structure modeling of the β1 subunit of the skeletal muscle voltage-gated sodium channel (Nav1.4) was carried out in the twilight zone of very low homology. Structural significance can per se be confounded with random sequence similarities. Hence, we combined (i) not automated computational modeling of weakly homologous 3D templates, some with interfaces to analogous structures to the pore-bearing Nav1.4 α subunit with (ii) site-directed mutagenesis (SDM), as well as (iii) electrophysiological experiments to study the structure and function of the β1 subunit. Despite the distant phylogenic relationships, we found a 3D-template to identify two adjacent amino acids leading to the long-awaited loss of function (inactivation) of Nav1.4 channels. This mutant type (T109A, N110A, herein called TANA) was expressed and tested on cells of hamster ovary (CHO). The present electrophysiological results showed that the double alanine substitution TANA disrupted channel inactivation as if the β1 subunit would not be in complex with the α subunit. Exhaustive and unbiased sampling of "all β proteins" (Ig-like, Ig) resulted in a plethora of 3D templates which were compared to the target secondary structure prediction. The location of TANA was made possible thanks to another "all β protein" structure in complex with an irreversible bound protein as well as a reversible protein-protein interface (our "Rosetta Stone" effect). This finding coincides with our electrophysiological data (disrupted β1-like voltage dependence) and it is safe to utter that the Nav1.4 α/β1 interface is likely to be of reversible nature.
These animal findings do not support clinical changes in channelopathies; leaves open reversible Nav1.4 subunit interfaces for further mutagenesis studies.
No takes yet. Share an insight, caveat, or question.
Scior et al. (2015) studied Nav1.4 channel function. Double alanine substitution TANA (T109A, N110A) was evaluated on Channel inactivation. The double alanine substitution TANA (T109A, N110A) in the Nav1.4 beta-1 subunit disrupted channel inactivation, suggesting the alpha/beta-1 interface is likely reversible.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: